PBI compared with HRMY: revenue, margins and what each company keeps, and the suppliers and customers both name

PBIPitney Bowes Inc

Mkt capRevenueRevenue

HRMYHarmony Biosciences Holdings, Inc.

Mkt capRevenueRevenue

Compare

PBIPitney Bowes Inc

HRMYHarmony Biosciences Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PBI 0

None

Shared 0

No disclosed counterparties: PBI.

Only HRMY 16

—Caremarkunlistedcustomer

—Accredo Healthunlistedcustomer

—PANTHERx Specialty Pharmacyunlistedcustomer

TMOThermo Fisher Scientificsupplier

12 more · HRMY chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PBIPitney Bowes Inc

15.81▼−1.92%

Mkt cap$2.2BRevenue$456MQ3 FY26Revenue$1.9BFY25

HRMYHarmony Biosciences Holdings, Inc.

37.85▼−0.16%

Regular sessionNov 3 '26

Mkt cap$2.2BRevenue$261MQ2 FY26Revenue$868MFY25

Compare

Regular sessionNov 3 '26

PBIPitney Bowes Inc

HRMYHarmony Biosciences Holdings, Inc.

15.81▼−1.92%

Price

37.85▼−0.16%

$2.2B

Mkt cap

$2.2B

Q3 FY26$456M

Revenue

$261MQ2 FY26

FY25$1.9B

Revenue

$868MFY25

PBI15.81▼−1.92%vsHRMY37.85▼−0.16%Regular sessionNov 3 '26